InvestorsHub Logo
Followers 2
Posts 379
Boards Moderated 0
Alias Born 12/04/2016

Re: gr8db8 post# 1079

Saturday, 07/08/2017 12:54:28 AM

Saturday, July 08, 2017 12:54:28 AM

Post# of 2099
Look at the charts from this new June presentation . People are alive with vb111. Even 2 from rgbm are alive but look the people who received avastin are all dead. 2 people are alive in rgbm and they didn't touch the devil avastin. And look also the poor number of months they live with the combo with avastin. The phase 2 results are great due to these 2 patients that never touch avastin. I m very very worried about the phase 3 because they gave the killer avastin to all participant. It will destroy the results . The one good thing only one from failure ph3 rgbm is that finally I hope they neglect the idea of combination in the company. The idea of combining any drug with vb111 is bad because it was already proven to be safe in combination . I also hope the company will neglect the idea of antiangiogenesis. Antiangiogenesis is not anti cancer. It's only anti cancer in doctors books and in their mind but not in real life. In real life it just cause damage and side effect and other negative influence like educating the tumor cells to work under hypoxic condition. The redemption will come only and I say clearly only when the company brains understand it's not them doing anything to the tumor. It's only that they put on the virus in the right place which is tumor area and all the work is being done by the immune system and any other drug even immunotherapy drugs will just disturb. Before they understand that we won't see improvements
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News